Role of Bile Acids and Gut Bacteria in GI Diseases
胆汁酸和肠道细菌在胃肠道疾病中的作用
基本信息
- 批准号:8698288
- 负责人:
- 金额:--
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2012
- 资助国家:美国
- 起止时间:2012-07-01 至 2016-06-30
- 项目状态:已结题
- 来源:
- 关键词:AcidsActive SitesAmino AcidsAndrogensApplications GrantsBacteriaBile AcidsBile fluidBindingBiochemical PathwayBiological AssayBloodChemicalsChenodeoxycholic AcidCholelithiasisCholesterolCholic AcidsClinical ResearchClostridiumColonColon CarcinomaDNADataDeoxycholic AcidDetectionDevelopmentDietDiseaseEcosystemEnterohepatic CirculationEnzyme KineticsEnzymesFecesFutureGene Expression ProfileGenesGlucocorticoidsGoalsGrowthHealthHospitalsHumanHuman MicrobiomeHydro-LyasesIncidenceIndividualIntestinesLaboratoriesLithocholic AcidLiverMammalian CellMetabolic BiotransformationMetabolismMolecularMonitorOxidoreductasePathway interactionsPatientsPhysiologicalPlayPopulationProstateProteinsRNAReverse Transcriptase Polymerase Chain ReactionRiskRoleSamplingSecondary toSite-Directed MutagenesisSteroid 17-alpha-monooxygenaseSteroidsSterolsSubstrate SpecificityTechniquesTimeTissuesVirginiaarmdehydroxylationdisorder riskin vivoinhibitor/antagonistmenmillimetermutantnovelpatient populationsteroid hormonethree dimensional structuretooltranscriptome sequencingtumor growth
项目摘要
DESCRIPTION (provided by applicant):
The human colon harbors one of the most densely populated bacterial ecosystems known (>1011 bacteria/g feces). Cholic acid (CA) and chenodeoxycholic acid (CDCA) are primary bile acids synthesized from cholesterol in the liver. Bile acids undergo enterohepatic circulation several times each day. Primary bile acids entering the colon are deconjugated and free bile acids are biotransformed to more than 20 different metabolites by gut bacteria. The major biotransformation is 7¿-dehydroxylation (7¿- DeOH) of CA and CDCA yielding the secondary bile acids deoxycholic acid (DCA) and lithocholic acid (LCA), respectively. Hydrophobic secondary bile acids are highly toxic to mammalian cells and can accumulate to high levels (>70%) in the bile acid pool of some individuals as the human liver cannot 7¿-hydroxylate secondary bile acids. High levels of DCA in blood, bile, and feces have been correlated with an increase risk of colon cancer and cholesterol gallstone disease, in some patients. The formation of secondary bile acids is carried out by a few species of the genus Clostridium and the level of these bacteria in feces is correlated with DCA levels in bile. The biochemical pathway of bile acid 7¿-DeOH has been elucidated by our group. However, many of the genes encoding enzymes in this pathway have not been isolated and characterized nor have the 3D structure of key enzymes in this pathway determined. Some strains of 7¿- dehydroxylating bacteria can convert glucocorticoids into C-19 androgenic compounds and the genes encoding these enzymes have not been isolated. Isolation of these genes is crucial for the development of molecular techniques (RT-PCR) to easily monitor intestinal bile acid and glucocorticoid metabolism and pharmacological or dietary ways to decrease formation of secondary bile acids and C-19 androgenic compounds. Subaim 1A. Identify CA, allo-CA, and glucocorticoid inducible genes from the human bile acid 7¿-dehydroxylating bacterium, Clostridium scindens ATCC 35704, via a wholetranscriptome approach (RNAseq). Subaim 1B. Develop quantitative PCR assays for key genes involved in allo-DCA and C-19 androgen formation. Aim 2. Characterize the allo-CA and glucocorticoid inducible enzymes from Clostridium scindens ATCC 35704 catalyzing the formation of allo-DCA acid and C-19 androgens, respectively. Aim 3: Determine the 3D structure of bile acid 7¿ and 7¿-dehydratases, the rate limiting enzymes in bile acid 7¿/7¿-DeOH, from Clostridium scindens. The results of these studies will give us the tools to carry out clinical studies to determine the most effective ways to decrease DCA in the bile acid pool with the aim of decreasing the risk of colon cancer and cholesterol gallstones, in some patients.
描述(由申请人提供):
人类结肠拥有已知最密集的细菌生态系统之一(>1011个细菌/g粪便)。胆酸(CA)和鹅去氧胆酸(CDCA)是由肝脏中的胆固醇合成的主要胆汁酸。胆汁酸每天进行数次肝肠循环。进入结肠的初级胆汁酸被解结合,游离胆汁酸被肠道细菌生物转化为20多种不同的代谢物。主要的生物转化是CA和CDCA的7 <$-脱羟基(7 <$- DeOH),分别产生二级胆汁酸脱氧胆酸(DCA)和石胆酸(LCA)。疏水性次级胆汁酸对哺乳动物细胞具有高毒性,并且可以在某些个体的胆汁酸库中积累至高水平(>70%),因为人类肝脏不能7-羟基化次级胆汁酸。血液、胆汁和粪便中高水平的DCA与某些患者结肠癌和胆固醇结石疾病的风险增加相关。次级胆汁酸的形成是由梭菌属的几个物种进行的,并且粪便中这些细菌的水平与胆汁中的DCA水平相关。本课题组已阐明了胆汁酸7 <$-DeOH的生化途径。然而,该途径中编码酶的许多基因尚未被分离和表征,也没有确定该途径中关键酶的3D结构。一些菌株7?β-脱羟基细菌可以将糖皮质激素转化为C-19雄激素化合物,编码这些酶的基因尚未分离。这些基因的分离是至关重要的分子技术(RT-PCR)的发展,以方便地监测肠道胆汁酸和糖皮质激素代谢和药理学或饮食的方式,以减少形成二级胆汁酸和C-19雄激素化合物。Subaim 1A.通过全转录组方法(RNAseq)鉴定来自人胆汁酸7-脱羟基细菌Clostridium glandens ATCC 35704的CA、allo-CA和糖皮质激素诱导基因。Subaim 1B.开发定量PCR检测方法,用于检测allo-DCA和C-19雄激素形成中的关键基因。目标2.表征分别催化异DCA酸和C-19雄激素形成的来自Clostridium glandens ATCC 35704的异DCA和糖皮质激素诱导酶。目的3:确定Clostridium dens中胆汁酸7 <$/7 <$-DeOH的限速酶胆汁酸7 <$$>和7 <$-脱氢酶的三维结构。这些研究的结果将为我们提供进行临床研究的工具,以确定减少胆汁酸池中DCA的最有效方法,目的是降低某些患者患结肠癌和胆固醇结石的风险。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
PHILLIP B HYLEMON其他文献
PHILLIP B HYLEMON的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('PHILLIP B HYLEMON', 18)}}的其他基金
Bile Acid and Sphingosine-1-phosphate Receptor-mediated Signaling in Cholestasis
胆汁酸和 1-磷酸鞘氨醇受体介导的胆汁淤积信号传导
- 批准号:
9024718 - 财政年份:2015
- 资助金额:
-- - 项目类别:
Bile Acids and Clostridium scindens Inhibit C. difficile: Role of Secreted Antibacterial Compounds
胆汁酸和梭菌抑制艰难梭菌:分泌的抗菌化合物的作用
- 批准号:
9233344 - 财政年份:2012
- 资助金额:
-- - 项目类别:
Role of Bile Acids and Gut Bacteria in GI Diseases
胆汁酸和肠道细菌在胃肠道疾病中的作用
- 批准号:
8536579 - 财政年份:2012
- 资助金额:
-- - 项目类别:
Role of Bile Acids and Gut Bacteria in GI Diseases
胆汁酸和肠道细菌在胃肠道疾病中的作用
- 批准号:
8324091 - 财政年份:2012
- 资助金额:
-- - 项目类别:
HIV Protease Inhibitors and Hepatic Lipid Dysregulation
HIV 蛋白酶抑制剂和肝脂质失调
- 批准号:
7035831 - 财政年份:2004
- 资助金额:
-- - 项目类别:
HIV Protease Inhibitors and Hepatic Lipid Dysregulation
HIV 蛋白酶抑制剂和肝脂质失调
- 批准号:
6799002 - 财政年份:2004
- 资助金额:
-- - 项目类别:
相似海外基金
Collaborative Research: Beyond the Single-Atom Paradigm: A Priori Design of Dual-Atom Alloy Active Sites for Efficient and Selective Chemical Conversions
合作研究:超越单原子范式:双原子合金活性位点的先验设计,用于高效和选择性化学转化
- 批准号:
2334970 - 财政年份:2024
- 资助金额:
-- - 项目类别:
Standard Grant
NSF-BSF: Towards a Molecular Understanding of Dynamic Active Sites in Advanced Alkaline Water Oxidation Catalysts
NSF-BSF:高级碱性水氧化催化剂动态活性位点的分子理解
- 批准号:
2400195 - 财政年份:2024
- 资助金额:
-- - 项目类别:
Standard Grant
Collaborative Research: Beyond the Single-Atom Paradigm: A Priori Design of Dual-Atom Alloy Active Sites for Efficient and Selective Chemical Conversions
合作研究:超越单原子范式:双原子合金活性位点的先验设计,用于高效和选择性化学转化
- 批准号:
2334969 - 财政年份:2024
- 资助金额:
-- - 项目类别:
Standard Grant
Mechanochemical synthesis of nanocarbon and design of active sites for oxygen reducton/evolution reactions
纳米碳的机械化学合成和氧还原/演化反应活性位点的设计
- 批准号:
23K04919 - 财政年份:2023
- 资助金额:
-- - 项目类别:
Grant-in-Aid for Scientific Research (C)
Creation of porous inorganic frameworks with controlled structure of metal active sites by the building block method.
通过积木法创建具有金属活性位点受控结构的多孔无机框架。
- 批准号:
22KJ2957 - 财政年份:2023
- 资助金额:
-- - 项目类别:
Grant-in-Aid for JSPS Fellows
Catalysis of Juxaposed Active Sites Created in Nanospaces and Their Applications
纳米空间中并置活性位点的催化及其应用
- 批准号:
23K04494 - 财政年份:2023
- 资助金额:
-- - 项目类别:
Grant-in-Aid for Scientific Research (C)
Generation of carbon active sites by modifying the oxygen containing functional groups and structures of carbons for utilizing to various catalytic reactions.
通过修饰碳的含氧官能团和结构来产生碳活性位点,用于各种催化反应。
- 批准号:
23K13831 - 财政年份:2023
- 资助金额:
-- - 项目类别:
Grant-in-Aid for Early-Career Scientists
CAREER: CAS: Understanding the Chemistry of Palladium and Silyl Compounds to Design Catalyst Active Sites
职业:CAS:了解钯和甲硅烷基化合物的化学性质以设计催化剂活性位点
- 批准号:
2238379 - 财政年份:2023
- 资助金额:
-- - 项目类别:
Continuing Grant
CAS: Collaborative Research: Tailoring the Distribution of Transient vs. Dynamic Active Sites in Solid-Acid Catalysts and Their Impacts on Chemical Conversions
CAS:合作研究:定制固体酸催化剂中瞬时活性位点与动态活性位点的分布及其对化学转化的影响
- 批准号:
2154399 - 财政年份:2022
- 资助金额:
-- - 项目类别:
Standard Grant
Engineering of Active Sites in Heterogeneous Catalysts for Sustainable Chemical and Fuel Production.
用于可持续化学和燃料生产的多相催化剂活性位点工程。
- 批准号:
RGPIN-2019-06633 - 财政年份:2022
- 资助金额:
-- - 项目类别:
Discovery Grants Program - Individual














{{item.name}}会员




